Dacarbazine and tamoxifen in patients with advanced melanoma: An effective therapy option?

被引：0
|
作者：
Rass, K
Seiter, S
Uhl, K
Petzoldt, D
Tilgen, W
机构：
[1] DEPT DERMATOL,HOMBURG,GERMANY
[2] UNIV SAARLAND,D-6600 SAARBRUCKEN,GERMANY
[3] UNIV HEIDELBERG,DEPT DERMATOL,D-6900 HEIDELBERG,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1170 / 1170
页数：2
相关论文
共 50 条
  • [31] Treatment of metastatic melanoma with a combination of carmustine, dacarbazine, cisplatin, tamoxifen and interferon alpha
    Haim, N
    Bernstein, Z
    Shklar, Z
    Steiner, M
    Stein, ME
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1165 - 1165
  • [32] Translational study on circulating markers in advanced melanoma patients undergoing Dacarbazine and Bevacizumab treatment
    Ferrucci, Pier Francesco
    Martinoli, Chiara
    Cocorocchio, Emilia
    Anichini, Andrea
    Gandini, Sara
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Melanoma: New Therapy Option
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (22) : 1537 - 1537
  • [34] 3-DRUG COMBINATION OF CISPLATIN, DACARBAZINE, AND TAMOXIFEN IN METASTATIC MALIGNANT-MELANOMA
    CHMIELOWSKA, E
    POTEMSKI, P
    PLUZANSKA, A
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 2146 - 2147
  • [35] Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma
    Plummer, R.
    Lorigan, P.
    Brown, E.
    Zaucha, R.
    Moiseyenko, V.
    Demidov, L.
    Soriano, V.
    Chmielowska, E.
    Andres, R.
    Kudryavtseva, G.
    Kahatt, C.
    Szyldergemajn, S.
    Extremera, S.
    de Miguel, B.
    Cullell-Young, M.
    Calvert, H.
    BRITISH JOURNAL OF CANCER, 2013, 109 (06) : 1451 - 1459
  • [36] Hypersensitivity to dacarbazine in patients with metastatic malignant melanoma
    Levy, A
    Guitera, P
    Kerob, D
    Ollivaud, L
    Archimbaud, A
    Dubertret, L
    Basset-Seguin, N
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2006, 133 (02): : 157 - 160
  • [37] Combined treatment with pegylated interferon-α-2a and dacarbazine in patients with advanced metastatic melanoma
    Hauschild, Axel
    Dummer, Reinhard
    Ugurel, Selma
    Kaehler, Katharina C.
    Egberts, Friederike
    Fink, Wolfram
    Both-Skalsky, Jeannine
    Laetsch, Barbara
    Schadendorf, Dirk
    CANCER, 2008, 113 (06) : 1404 - 1411
  • [38] Long-term survival of patients (pts) with advanced melanoma treated with ipilimumab with or without dacarbazine
    Hersh, E.
    Weber, J.
    Powderly, J.
    Pavlik, A.
    Nichol, G.
    Yellin, M.
    Cranmer, L.
    Urba, W.
    O'Day, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group
    Bedikian, Agop Y.
    Millward, Michael
    Pehamberger, Hubert
    Conry, Robert
    Gore, Martin
    Trefzer, Uwe
    Pavlick, Anna C.
    DeConti, Ronald
    Hersh, Evan M.
    Hersey, Peter
    Kirkwood, John M.
    Haluska, Frank G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4738 - 4745
  • [40] Enhanced dacarbazine efficacy in advanced melanoma patients previously treated with immune checkpoint inhibitors in Korea
    Lee, Soo Jung
    Na, Jihyun
    Lee, In Hee
    Lee, Jeeyeon
    Lee, Seok-Jong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345